KBR to Conduct Medical Research of Biomedical Impacts on Airmen

HOUSTON , June 11, 2022 /PRNewswire/ -- KBR (NYSE:KBR ) was awarded a strategic contract to expand its health and human performance research and development (R&D) support of the 711th Human Performance Wing, a unit of the Air Force Research Laboratory (AFRL). Under this 3-year $20 million contract, KBR will provide scientific support focused on airman readiness medical research. The cost-plus-fixed-fee contract leverages KBR's existing R&D efforts at AFRL onto a new agreement with an increased scope of work. Under the terms of the award, KBR will provide scientific and medical expertise to AFRL at Wright-Patterson Air Force Base. KBR human health and performance specialists will investigate airmen readiness to include the biomedical impacts of air and space as well as cognitive and physiological performance.  KBR will support aerospace physiology research in Wright-Patterson's new centrifuge and research altitude chambers facilities in Ohio , as well as Neurology, Operational Vision and Enroute Care studies. "With professional services ranging from biomedical to health science, ... Full story available on Benzinga.com